Case Studies >
Factorial Biotechnologies is the only company that provides in-cell library prep for single-cell sequencing at cost, workflow, and content parity to bulk NGS libraries for research laboratories and pharmaceutical companies that want to leverage the power of single-cell NGS to drive the discovery of novel therapeutics.
The Samba Approach
Factorial wanted to come out of stealth mode and announce to the world that they were ready to promote their innovative and game changer in-cell library prep technology.
As the first step to bringing Factorial’s technology to light and building awareness, we promoted their collaboration with Watchmaker Genomics, a recognized advanced enzymology company, by releasing a press release highlighting how they synergized to simplify single-cell sequencing. Additionally, we coordinated a media interview with GenomeWeb, an established scientific news media outlet.
Factorial and Watchmaker press release was a hit. After publishing the press release, Factorial’s contact us form fills grew by 5.75X, and 69 new ones were created. Additionally, Factorial CEO, John Wells, was interviewed by GenomeWeb, and the interview was featured on their main web page.
"I have been quite happy with Samba. They laid out a comprehensive plan to bring Factorial to the public and executed it really well"
"The quality of the deliverables is great. Samba understands the fundamental science behind our technology and merges that knowledge with a great production team that effectively positions our brand in the single-cell sequencing space"